Warts Therapeutics Market Report 2026

Warts Therapeutics Market Overview

• Warts Therapeutics market size has reached to $2.01 billion in 2025 • Expected to grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.5% • Growth Driver: Driving Growth In The Wart Therapeutics Market Through Enhanced Availability Of Medical Services • Market Trend: Vial And Nielsen Biosciences Join Forces To Propel Candin Phase 3 Clinical Trial • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Warts Therapeutics Market?

Wart’s therapeutics refers to medical drugs and medicines that exert therapeutic effects in treating the skin condition known as warts disease, caused by the human papillomavirus (HPV). Wart therapeutics are used to treat a wide range of wart diseases caused by the hands, face, and feet. The main types of warts in warts therapeutics are common warts, genital warts, flat warts, and others. Common warts are tiny, grazed skin growths that typically appear on the hands or fingers. These are treated using physical destruction, immunomodulation, and chemical destruction. The warts therapeutics are used by hospitals, homecare, specialty clinics, and others.

What Is The Warts Therapeutics Market Growth Forecast?

The warts therapeutics market size is expected to see steady growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to advances in biologics and immunomodulators, rising awareness about hpv vaccination, growth in homecare treatment solutions, increasing dermatology clinical trials, expansion of dermatology-focused healthcare infrastructure. Major trends in the forecast period include rising prevalence of hpv-related skin disorders, development of topical and targeted therapeutics, increased focus on pediatric dermatology, expansion of homecare and otc wart treatments, growing adoption of combination therapies.

Global Warts Therapeutics Market Segmentation

1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types 2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction 3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4 2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11 3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms 4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts

What Is The Driver Of The Warts Therapeutics Market?

The rise in accessibility to healthcare services is expected to propel the growth of the wart therapeutics market going forward. Healthcare services refer to the provision of medical care, treatment, and support to individuals to maintain or improve their health. Healthcare services use wart therapeutics to address and treat common skin conditions caused by the human papillomavirus (HPV). These treatments are employed to alleviate symptoms, promote healing, and prevent the spread of warts, contributing to the overall well-being of individuals. For instance, in April 2025, according to the Office for the National Statistics, a UK-based organization, provisional estimates indicate that nominal UK healthcare expenditure reached approximately $414.03 billion (£317 billion) in 2024, reflecting a 6.5% increase in cash spending compared with 2023. Therefore, the rise in accessibility to healthcare services is driving the growth of the wart therapeutics market.

Key Players In The Global Warts Therapeutics Market

Major companies operating in the warts therapeutics market are GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd, Cipla Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Compound W, Duofilm, MedCara Pharmaceuticals, Novan Inc, Prestige Consumer Healthcare Inc., KinoPharma Inc., Phio Pharmaceuticals Corp., Emblation Ltd., Meda Pharmaceuticals, Dermira Inc., Celgene Corporation, Akorn Pharmaceuticals, Biofrontera AG, Medicis Pharmaceutical Corporation

Global Warts Therapeutics Market Trends and Insights

Major companies operating in the wart therapeutics market are adopting a strategic partnership approach to support Nielsen's phase 3 clinical trial of CANDIN for the treatment of common warts. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2023, Vial, a US-based pharmaceuticals company, partnered with Nielsen BioSciences Inc., a US-based pharmaceuticals company. With this partnership, they aim to study the safety and efficacy of CANDIN, a diagnostic skin test that is for the treatment of common warts, and contribute to the development of new therapies and devices for sponsors and patients.

What Are Latest Mergers And Acquisitions In The Warts Therapeutics Market?

In July 2025, Verrica Pharmaceuticals, a US-based provider of dermatology therapeutics and skin disease treatments, partnered with Torii Pharmaceutical Co. Ltd. to co-fund and advance a global phase 3 clinical trial of YCANTH (VP-102) for the treatment of common warts, thereby expanding its presence in the warts therapeutics market and strengthening its dermatology product pipeline. Torii Pharmaceutical Co. Ltd. is a Japan-based company that specializes in the development and manufacturing of pharmaceutical products.

Regional Insights

North America was the largest region in the warts therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Warts Therapeutics Market?

The warts therapeutics market consists of sales of therapeutic drugs such as 5-fluorouracil, benzalkonium, glutaraldehyde, cryotherapy, or podophyllin. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Warts Therapeutics Market Report 2026?

The warts therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the warts therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.